Upside Surprises More Likely Than Downside for Alexion Pharmaceuticals, Says Credit Suisse


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares have plummeted 35 percent year-to-date. Credit Suisse’s Alethia Young upgraded the rating on the company from Neutral to Outperform, while reducing the price target from $186 to $165.

Following the pullback, Alexion Pharma’s shares now reflect biosimilar and competition risk, while the company has various pipeline products that could lend upside, analyst Alethia Young commented. She added that the stock appeared to have “more potential for upside surprises than downside surprise” at the current level, with ~60 percent upside versus ~20 percent downside.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Soliris Estimates

“Expectations around Soliris growth long-term growth have pulled back significantly over 1H16. With a potential 1210 (next-gen Soliris) approval in 2018, we thought that it was reasonable to separate our Soliris estimates from our 1210 estimate,” Young wrote.

The new Soliris+1210 estimate for 2020 is at $3.9B, below consensus expectation of $4.3B, with the gap possibly arising from “our probability adjustment of 1210,” the analyst noted.

Kanuma Estimates

The 2020 estimate for Kanuma has been reduced from $581M to $249M, versus the consensus expectation of $490M, which has resulted in the downward revision of the price target.

Did you like this article? Could it have been improved? Please email feedback@benzinga.com to let us know!


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorBiotechLong IdeasUpgradesHealth CarePrice TargetAnalyst RatingsTrading IdeasGeneralAlethia YoungCredit Suisse